These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 3924751)

  • 1. Iron status in Sicilian subjects with beta-thalassemia trait.
    Musumeci S; Romeo MA; Di Gregorio F; Testa R; Schiliro' G
    Haematologica; 1985; 70(1):1-5. PubMed ID: 3924751
    [No Abstract]   [Full Text] [Related]  

  • 2. [Findings in relation to serum and urinary iron in heterozygotic beta-thalassemia].
    Lodi G; Squarzoni G; Bariani MC; Fogli B; Masotti M; Musiari A; Bariani L
    G Clin Med; 1989 Apr; 70(4):263-6. PubMed ID: 2767366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Iron status in Sicilian subjects with beta-thalassemia trait.
    Musumeci S; Romeo MA; Di Gregorio F; Testa R; Schiliro G
    Birth Defects Orig Artic Ser; 1988; 23(5B):19-24. PubMed ID: 3390540
    [No Abstract]   [Full Text] [Related]  

  • 4. [Thalassemia trait in the pediatric age and body iron status].
    Abreu de Miani MS; Calvo EB; Sanchís ME; Peñalver JA
    Sangre (Barc); 1986; 31(1):1-6. PubMed ID: 3704880
    [No Abstract]   [Full Text] [Related]  

  • 5. Iron status and anemia in thalassemic Sardinian carriers.
    Pardini S; Dore F; Oggiano L; Bonfigli S; Pacifico S; Campus S; Longinotti M
    Haematologica; 1986; 71(1):17-9. PubMed ID: 3084350
    [No Abstract]   [Full Text] [Related]  

  • 6. The iron status of Italian subjects with beta-thalassemia trait.
    Fargion S; Taddei MT; Cappellini MD; Piperno A; Fiorelli G
    Acta Haematol; 1982; 68(2):109-14. PubMed ID: 6812365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urine iron excretion in beta-thalassemia trait.
    Camerini G; Voghenzi A; Kalapurackal M
    Boll Soc Ital Biol Sper; 1987 Apr; 63(4):317-21. PubMed ID: 3447608
    [No Abstract]   [Full Text] [Related]  

  • 8. [Evaluation of iron "status" in heterozygote beta-thalassemia. Indications and counterindications for martial treatment].
    Soffritti E; Bernardoni R; Ferrari R; Dall'Ara G; Farina F; Pelizzola D
    Riv Eur Sci Med Farmacol; 1988 Jun; 10(3):209-18. PubMed ID: 3274710
    [No Abstract]   [Full Text] [Related]  

  • 9. Levels of non-transferrin-bound iron as an index of iron overload in patients with thalassaemia intermedia.
    Taher A; Musallam KM; El Rassi F; Duca L; Inati A; Koussa S; Cappellini MD
    Br J Haematol; 2009 Sep; 146(5):569-72. PubMed ID: 19604239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Chelating therapy in beta-thalassemia].
    Musumeci S; Romeo MA; Di Gregorio F; Schiliró G; Russo G
    Pediatr Med Chir; 1982; 4(1-2):55-9. PubMed ID: 7111040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation of liver iron concentration determined by R2 magnetic resonance imaging with serum ferritin in patients with thalassemia intermedia.
    Taher A; El Rassi F; Isma'eel H; Koussa S; Inati A; Cappellini MD
    Haematologica; 2008 Oct; 93(10):1584-6. PubMed ID: 18728025
    [No Abstract]   [Full Text] [Related]  

  • 12. Hemoglobinization and functional availability of iron for erythropoiesis in case of thalassemia and iron deficiency anemia.
    Bartels PC; Schoorl M; Schoorl M
    Clin Lab; 2006; 52(3-4):107-14. PubMed ID: 16584056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Iron deficiency anaemia].
    Leporrier M; Seguin A
    Rev Prat; 2004 Jan; 54(2):217-23. PubMed ID: 15086065
    [No Abstract]   [Full Text] [Related]  

  • 14. Serum ferritin underestimates liver iron concentration in transfusion independent thalassemia patients as compared to regularly transfused thalassemia and sickle cell patients.
    Pakbaz Z; Fischer R; Fung E; Nielsen P; Harmatz P; Vichinsky E
    Pediatr Blood Cancer; 2007 Sep; 49(3):329-32. PubMed ID: 17554789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hematologic values in subjects with thalassemic diseases after periodic bloodletting].
    Morgagni C
    Boll Soc Ital Biol Sper; 1967 Dec; 43(23):1645-8. PubMed ID: 5589071
    [No Abstract]   [Full Text] [Related]  

  • 16. Evaluation of serum iron and ferritin levels in alopecia areata.
    Esfandiarpour I; Farajzadeh S; Abbaszadeh M
    Dermatol Online J; 2008 Mar; 14(3):21. PubMed ID: 18627722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Is there sufficient awareness of thalassemia syndromes? A screening method for these hereditary disorders].
    van Waveren Hogervorst GD; Bartels PC; Helleman PW
    Ned Tijdschr Geneeskd; 1986 Jan; 130(2):68-72. PubMed ID: 3005888
    [No Abstract]   [Full Text] [Related]  

  • 18. Erythroid bone marrow activity and red cell hemoglobinization in iron sufficient beta-thalassemia heterozygotes as reflected by soluble transferrin receptor and reticulocyte hemoglobin in content. Correlation with genotypes and Hb A(2) levels.
    Skarmoutsou C; Papassotiriou I; Traeger-Synodinos J; Stamou H; Ladis V; Metaxotou-Mavrommati A; Stamoulakatou A; Kanavakis E
    Haematologica; 2003 Jun; 88(6):631-6. PubMed ID: 12801838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Serum ferritin in the follow-up of homozygotic beta-thalassemia treated with blood transfusion and iron-chelating agents].
    Esposito L; Ferrara M; Ponte G
    Pediatria (Napoli); 1981 Sep; 89(3):479-92. PubMed ID: 7346759
    [No Abstract]   [Full Text] [Related]  

  • 20. [Damage of iron metabolism and oxidoreduction process in children with beta-thalassemia].
    Mtvarelidze ZG; Kvezereli-Kopadze AN; Kvezereli-Kopadze MN
    Georgian Med News; 2006 Jul; (136):69-71. PubMed ID: 16905850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.